Healthcare Services

Osteoporosis Treatment Industry Expansion Forecast Showing Market Size of $18.72 Billion by 2030 at 5.2% CAGR

April 3, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Osteoporosis Treatment Market Between 2026 And 2030?

The osteoporosis treatment market size has shown consistent expansion in recent years. It is anticipated to increase from $14.57 billion in 2025 to $15.27 billion in 2026, registering a compound annual growth rate (CAGR) of 4.8%. The observed growth during the historical period stems from factors such as the rising incidence of osteoporosis among the elderly, the initial scarcity of advanced osteoporosis therapies, increasing public understanding of bone health and methods to prevent fractures, the early adoption of calcium and vitamin D supplementation, and the growing number of older individuals with co-existing health issues that affect bone health.

The osteoporosis treatment market is projected for significant expansion over the coming years. Its size is anticipated to reach $18.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period is fueled by several factors, such as the increasing acceptance of targeted drug therapies, including rankl inhibitors and pth analogs, the growing application of digital diagnostics and AI-based monitoring, the development of healthcare infrastructure for osteoporosis management, increased funding for preventive and lifestyle-oriented interventions, and enhanced patient awareness and compliance with treatment programs. Key developments expected during this period involve a greater uptake of bisphosphonates and rankl inhibitors, a rise in the utilization of injectable osteoporosis therapies, wider incorporation of AI-based bone density monitoring, an increased emphasis on individualized osteoporosis management plans, and heightened investment in preventive care and lifestyle improvements.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Osteoporosis Treatment Market?

The increasing healthcare expenditures are projected to drive the expansion of the osteoporosis treatment market. Healthcare expenditures refer to the total funds allocated to medical services and products within a particular period, typically assessed at a regional, national, or global scale. Osteoporosis treatment contributes significantly to the escalation of healthcare expenditures by covering costs associated with diagnostic tests, medications, rehabilitation services, and potential surgeries. For instance, in May 2024, the Office for National Statistics, a UK-based national statistical institute, reported that UK healthcare expenditure reached approximately $384.3 billion (£292 billion) in 2023, rising from $372.1 billion (£283 billion) in 2022. Therefore, the upward trend in healthcare expenditures is a key factor propelling the growth of the osteoporosis treatment market.

Which Market Segments Are Examined In The Osteoporosis Treatment Market Study?

The osteoporosis treatment market covered in this report is segmented –

1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog

2) By Route Of Administration: Oral, Injectable, Other Routes Of Administration

3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid

2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations

3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)

4) By Selective Estrogen Receptor Modulators (SERMs): Raloxifene, Bazedoxifene

5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide)

Which Trends Are Shaping The Future Of The Osteoporosis Treatment Market?

Leading firms in the osteoporosis treatment sector are prioritizing the creation of sophisticated injectable therapies to maintain their market standing. These injectable treatments are medicines administered through injections, designed to hinder bone degradation and lower the likelihood of fractures in people with osteoporosis. Such alternatives offer an immediate means of enhancing bone density and bolstering skeletal well-being. As an example, in November 2023, Apotex Corp., a pharmaceutical company based in Canada, introduced Teriparatide Injection. This product is a pre-filled pen designed for individual patient application in managing osteoporosis. Each pen provides a concentration of 250 mcg/mL and delivers 28 daily doses, with each dose being 20 mcg. The aim of this product is to improve availability of cost-effective treatment for approximately 10 million Americans affected by osteoporosis. Its creation highlights Apotex’s commitment to manufacturing intricate generic medicines, thereby guaranteeing patients access to superior quality care.

Who Are The Primary Competitors In The Osteoporosis Treatment Market?

Major companies operating in the osteoporosis treatment market are Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Radius Health Inc., UCB SA, Entera Bio Ltd, Cipla Limited, Sun Pharmaceutical Industries Ltd, Sanofi, Johnson & Johnson Services Inc, Bayer AG, Bristol-Myers Squibb Company, Kyowa Kirin Co Ltd, Teijin Pharma Ltd, Zhejiang Hisun Pharmaceutical Co Ltd, Jiangsu Hengrui Medicine Co Ltd, Servier Laboratories, Apotex Inc, Dr Reddy’s Laboratories Ltd, Ipsen

Read the full osteoporosis treatment market report here:

https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

What Are The Leading Geographic Regions In The Osteoporosis Treatment Market?

North America was the largest region in the osteoporosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Osteoporosis Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12166&type=smp

Browse Through More Reports Similar to the Global Osteoporosis Treatment Market 2026, By The Business Research Company

Osteoporosis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

Osteoporosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

Metastatic Bone Disease Global Market Report

https://www.thebusinessresearchcompany.com/report/metastatic-bone-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795